Deferred Tax Assets, Valuation Allowance of Marker Therapeutics, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Marker Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Marker Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $40,997,000, a 3.2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Marker Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $40,997,000 +$1,288,000 +3.2% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $39,709,000 -$1,556,000 -3.8% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $41,265,000 +$4,864,000 +13% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q4 2021 $36,401,000 +$6,712,000 +23% 31 Dec 2021 10-K 17 Mar 2022 2021 FY
Q4 2020 $29,689,000 +$5,057,000 +21% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 $24,632,000 +$4,680,000 +23% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q4 2018 $19,952,000 +$8,074,000 +68% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 $11,878,000 -$1,914,000 -14% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q4 2016 $13,792,000 +$2,966,000 +27% 31 Dec 2016 10-K 23 Mar 2018 2017 FY
Q4 2015 $10,826,000 -$1,645,000 -13% 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q4 2014 $12,471,000 +$23,678,000 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q4 2013 $11,207,000 31 Dec 2013 10-K 15 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.